Clinical trial
Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-Vivo
NCT00162422 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00162422 |
|---|---|
| Title | Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-Vivo |
| Official title | The Effect of β2 Genetic Polymorphisms on the Brochodilatation Effect of Albuterol ex-Vivo |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | albuterol |
| Enrollment | 150 |
| Start date | Aug 1, 2003 |
| First posted | Sep 13, 2005 |
| Last update posted | Oct 29, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: